Carrs公司推出对抗超级细菌的新型武器

一种新研制的对抗耐甲氧西林金黄色葡萄球菌（MRSA）的新武器，具有持久灭菌包膜，能够99.8%地限制MRSA的生长。

Biacticap正在被用于作为无碳纸张的包膜，独立的检测结果发现其能够有效地抑制MRSA的生长。用于医生笔记本和患者病历的纸张是各种细菌包括MRSA的良好的宿主和携带者，能够在医生与患者之间、患者与医院雇员之间、以及医院不同科室之间引起交叉感染。

Biacticap是由Carrs产品公司研制开发的，这是一家生产包膜纸张的制造商。这种包膜能够有效对抗细菌，包括李斯特菌、大肠杆菌和沙门氏菌。Carrs公司计划扩大治疗范围，将其扩展至柔软的物质例如塑料、薄膜、非纺织品物质、以及纺织品，这样Biacticap就可以保护绝大多数医院内的柔软的表面。

Carrs公司市场与销售部主任Tony Davis说：“由于突变，细菌能够迅速对抗生素产生抵抗，因此是一种潜在的健康威胁。不同的是，Biacticap是无机产品，能够对细菌突变提供持续的保护作用，而且细菌突变不会对它的抗微生物作用产生免疫。”
 
New Weapon Against Superbugs
 
A newly developed weapon against superbug methicillin-resistant Staphylococcus aureus (MRSA) is a permanent biocidal coating that is 99.8% effective in limiting the growth of MRSA.

Biacticap is being used as a coating for carbonless paper, where independent testing has found it to be effective in limiting the growth of MRSA. Paper, used for doctors’ notes and patient records, is an excellent host and carrier for all types of bacteria including MRSA, serving as a mechanism for cross-contamination between doctors and patients, patients and hospital employees, and between different hospital departments.

Biacticap was developed by Carrs Products (Birmingham, UK), a manufacturer of coated papers. The coating is also effective against other bacteria, including Listeria, Escherichia coli, and Salmonella. Carrs Products plans to extend the treatment to other flexible substrates such as plastics, film, nonwoven materials, and textiles, so that Biacticap would be able to protect most flexible surfaces in the hospital.

“Bacteria can quickly become resistant to antibiotics as a result of mutation, and therefore represent an ongoing healthcare threat,” said Tony Davis, sales and marketing director of Carrs Products. “In contrast, because Biacticap is inorganic, it provides continuous protection against bacteria mutations, which cannot become immune to its antimicrobial action.”